Evidence map›Paper›PMID 32864045›Full record

ArticleWorld journal of gastrointestinal oncology2020

Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer.

Tian-Yu Xie, Di Wu, Shuo Li, Zhao-Yan Qiu, Qi-Ying Song, Da Guan, Li-Peng Wang, Xiong-Guang Li, Feng Duan, Xin-Xin Wang

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastrointestinal oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 6 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 6 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review of 2022 PSOGI/RENAPE Consensus on HIPEC.Journal of surgical oncology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review.International journal of environmental research and public health · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tian-Yu XieSchool of Medicine, Nankai University, Tianjin 300071, China.
Di WuDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Shuo LiSchool of Medicine, Nankai University, Tianjin 300071, China.
Zhao-Yan QiuDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Qi-Ying SongDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Da GuanDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Li-Peng WangDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Xiong-Guang LiSchool of Medicine, Nankai University, Tianjin 300071, China.
Feng DuanDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Xin-Xin WangDepartment of General Surgery, Chinese PLA General Hospital, Beijing 100853, China. 301wxx@sina.com.
Chinese PLA General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric cancer is the second most common malignant tumor in China, ranking third among all malignant tumor mortality rates. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been shown to increase significantly the effectiveness of intraperitoneal chemotherapeutic drugs, prolong the action time of these drugs on intraperitoneal tumor cells, and enhance their diffusion in tumor tissues. HIPEC may be one of the best choices for the eradication of residual cancer cells in the abdominal cavity.

aimThe aim of this study was to study the role of preventive HIPEC after radical gastrectomy.

methodsA prospective analysis was performed with patients with cT

resultsThe first site of tumor recurrence was the peritoneum in 11 cases in the conventional adjuvant chemotherapy group and in 2 cases in the HIPEC group (

conclusionIn patients with cT

Indexed as

Disease-free survivalGastric cancerHyperthermic intraperitoneal chemotherapyLocally advancedOverall survivalPrognosis

Identifiers

PMID32864045
PMCPMC7428793
OpenAlexW3042886711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.